• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FIPS 评分对全国退伍军人事务队列中 TIPS 术后死亡率的外部验证。

External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.

机构信息

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

Dig Dis Sci. 2022 Sep;67(9):4581-4589. doi: 10.1007/s10620-021-07307-5. Epub 2021 Nov 19.

DOI:10.1007/s10620-021-07307-5
PMID:34797445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9117561/
Abstract

BACKGROUND

The Freiburg index of post-TIPS survival (FIPS) score was recently demonstrated to improve prediction of post-TIPS mortality relative to existing standards. As this score was derived from a German cohort over an extended time period, it is unclear if performance will translate well to other settings. This study aimed to externally validate the FIPS score in a large Veterans Affairs (VA) cohort over two separate eras of TIPS-related care.

METHODS

This was a retrospective cohort study of patients with cirrhosis who underwent TIPS placement in the VA from 2008 to 2020. Cox regression models for post-TIPS survival were constructed using FIPS, MELD, MELD-Na, or CTP scores as predictors. Discrimination (Harrell's C) and calibration (joint tests of calibration curve slope and intercept) were evaluated for each score. A stratified analysis was performed for time periods between 2008-2013 and 2014-2020.

RESULTS

The cohort of 1,274 patients was 97.3% male with mean age 60.9 years and mean MELD-Na 14. The FIPS score demonstrated the highest overall discrimination versus MELD, MELD-Na, and CTP (0.634 vs. 0.585, 0.626, 0.612, respectively). However, in the modern treatment era (2014-2020), the FIPS score performed similarly to MELD-Na. Additionally, the FIPS score demonstrated poor calibration at one-month and six-month post-TIPS timepoints (joint p = 0.04 and 0.004, respectively). MELD, MELD-Na, and CTP were well-calibrated at each timepoint (each joint p > 0.05).

CONCLUSION

The FIPS score performed similarly to MELD-Na in the modern TIPS treatment era and demonstrated regions of poor calibration. Future models derived with contemporary data may improve prediction of post-TIPS mortality.

摘要

背景

弗赖堡经颈静脉肝内门体分流术(TIPS)后生存指数(FIPS)评分最近被证明可提高 TIPS 术后死亡率的预测能力,优于现有标准。由于该评分是从德国队列在较长时间内得出的,因此尚不清楚其在其他环境中的表现是否会很好。本研究旨在通过 VA 两个不同 TIPS 相关治疗时期的大型队列来对 FIPS 评分进行外部验证。

方法

这是一项回顾性队列研究,纳入了 2008 年至 2020 年期间在 VA 接受 TIPS 治疗的肝硬化患者。使用 FIPS、MELD、MELD-Na 或 CTP 评分作为预测因素,构建 TIPS 术后生存的 Cox 回归模型。评估每个评分的区分度(哈雷尔 C 指数)和校准度(校准曲线斜率和截距的联合检验)。对 2008-2013 年和 2014-2020 年两个时间段进行分层分析。

结果

队列中的 1274 名患者均为男性,占 97.3%,平均年龄为 60.9 岁,平均 MELD-Na 为 14。FIPS 评分在 MELD、MELD-Na 和 CTP 评分中表现出最高的总体区分度(0.634 比 0.585、0.626、0.612)。然而,在现代治疗时期(2014-2020 年),FIPS 评分与 MELD-Na 表现相似。此外,FIPS 评分在 TIPS 术后 1 个月和 6 个月时的校准效果较差(联合 p=0.04 和 0.004)。MELD、MELD-Na 和 CTP 在每个时间点的校准效果都很好(每个联合 p>0.05)。

结论

在现代 TIPS 治疗时代,FIPS 评分与 MELD-Na 表现相似,并显示出校准效果不佳的区域。使用当代数据得出的未来模型可能会提高 TIPS 术后死亡率的预测能力。

相似文献

1
External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.FIPS 评分对全国退伍军人事务队列中 TIPS 术后死亡率的外部验证。
Dig Dis Sci. 2022 Sep;67(9):4581-4589. doi: 10.1007/s10620-021-07307-5. Epub 2021 Nov 19.
2
FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.经颈静脉肝内门体分流术(TIPS)后生存预测的 FIPS 评分:在中国肝硬化患者队列中的外部验证及与传统风险评分的比较。
AJR Am J Roentgenol. 2022 Aug;219(2):255-267. doi: 10.2214/AJR.21.27301. Epub 2022 Feb 9.
3
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.使用新型弗赖堡经颈静脉肝内门体分流术后生存指数优化经颈静脉肝内门体分流术后生存预测。
J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26.
4
Validating the prognostic value of Freiburg index of posttransjugular intrahepatic portosystemic shunt survival score and classic scores in Chinese patients with implantation of transjugular intrahepatic portosystemic shunt.验证 Freiburg 经颈静脉肝内门体分流术生存评分和经典评分在中国人行经颈静脉肝内门体分流术患者中的预后价值。
Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1074-1080. doi: 10.1097/MEG.0000000000002427. Epub 2022 Aug 24.
5
MELD 3.0 Score for Predicting Survival in Patients with Cirrhosis After Transjugular Intrahepatic Portosystemic Shunt Creation.MELD3.0 评分预测经颈静脉肝内门体分流术创建后肝硬化患者的生存。
Dig Dis Sci. 2023 Jul;68(7):3185-3192. doi: 10.1007/s10620-023-07834-3. Epub 2023 Jan 30.
6
The Added Value of Sarcopenia on Existing Risk Scores to Predict Mortality after TIPS Placement: A Multicenter Study.肌肉减少症对 TIPS 放置后死亡率预测的现有风险评分的增值:一项多中心研究。
Acad Radiol. 2023 Sep;30 Suppl 1:S246-S256. doi: 10.1016/j.acra.2023.03.011. Epub 2023 Apr 5.
7
Predictive Accuracy Comparison of Prognostic Scoring Systems for Survival in Patients Undergoing TIPS Placement: A Systematic Review and Meta-analysis.经 TIPS 置入术治疗的患者生存预后评分系统预测准确性的比较:系统评价和荟萃分析。
Acad Radiol. 2024 Sep;31(9):3688-3710. doi: 10.1016/j.acra.2023.10.050. Epub 2023 Nov 23.
8
Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt.纳入肌肉减少症可提高经颈静脉肝内门体分流术后患者 MELD 评分的预后价值。
Eur J Gastroenterol Hepatol. 2022 Sep 1;34(9):948-955. doi: 10.1097/MEG.0000000000002391. Epub 2022 May 23.
9
Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.经颈静脉肝内门体分流术后患者生存的腰大肌密度预测:一项回顾性队列研究。
Med Sci Monit. 2022 Jan 15;28:e934057. doi: 10.12659/MSM.934057.
10
MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.MELD 或 Sodium MELD:两种评分系统预测经颈静脉肝内门体分流术放置后结局的能力比较。
AJR Am J Roentgenol. 2020 Jul;215(1):215-222. doi: 10.2214/AJR.19.21726. Epub 2020 May 20.

引用本文的文献

1
Prognostic Performance of Model for End-Stage Liver Disease (MELD) 3.0 for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation.终末期肝病模型(MELD)3.0在经颈静脉肝内门体分流术(TIPS)创建中的预后性能。
Cardiovasc Intervent Radiol. 2025 Jul 14. doi: 10.1007/s00270-025-04116-5.
2
The unwell patient with advanced chronic liver disease: when to use each score?患有晚期慢性肝病的不适患者:何时使用每种评分?
BMC Med. 2025 Jul 9;23(1):413. doi: 10.1186/s12916-025-04185-w.
3
Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension.

本文引用的文献

1
External validation of the Freiburg index of post-TIPS survival.经颈静脉肝内门体分流术后生存的弗莱堡指数的外部验证
J Hepatol. 2021 Sep;75(3):746-747. doi: 10.1016/j.jhep.2021.04.027. Epub 2021 Apr 26.
2
Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS?经颈静脉肝内门体分流术(TIPS)后生存的弗莱堡指数(FIPS):肝硬化患者有效的预后评分,还是反对TIPS的一项参考指标?
J Hepatol. 2021 Aug;75(2):487-489. doi: 10.1016/j.jhep.2021.02.031. Epub 2021 Mar 12.
3
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
门静脉高压患者经颈静脉肝内门体分流术(TIPS)后的分流功能障碍与死亡率
Insights Imaging. 2024 Aug 7;15(1):193. doi: 10.1186/s13244-024-01768-8.
4
External validation of the modified CTP score based on ammonia to predict survival in patients with cirrhosis after TIPS placement.基于血氨的改良 CTP 评分对 TIPS 术后肝硬化患者生存的外部验证。
Sci Rep. 2024 Jun 16;14(1):13886. doi: 10.1038/s41598-024-64793-z.
5
Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study.使用弗赖堡经颈静脉肝内门体分流术后生存指数(FIPS)对急性慢性肝衰竭重症患者进行生存预测:一项回顾性观察研究。
Front Med (Lausanne). 2022 Dec 22;9:1042674. doi: 10.3389/fmed.2022.1042674. eCollection 2022.
使用新型弗赖堡经颈静脉肝内门体分流术后生存指数优化经颈静脉肝内门体分流术后生存预测。
J Hepatol. 2021 Jun;74(6):1362-1372. doi: 10.1016/j.jhep.2021.01.023. Epub 2021 Jan 26.
4
Transjugular Intrahepatic Portosystemic Shunt Placement for Portal Hypertension: Meta-Analysis of Safety and Efficacy of 8 mm vs. 10 mm Stents.经颈静脉肝内门体分流术治疗门静脉高压:8mm与10mm支架安全性和有效性的Meta分析
Gastroenterol Res Pract. 2020 Oct 17;2020:9149065. doi: 10.1155/2020/9149065. eCollection 2020.
5
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
6
MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.MELD 或 Sodium MELD:两种评分系统预测经颈静脉肝内门体分流术放置后结局的能力比较。
AJR Am J Roentgenol. 2020 Jul;215(1):215-222. doi: 10.2214/AJR.19.21726. Epub 2020 May 20.
7
Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.在经颈静脉肝内门体分流术(TIPS)前进行风险分层时,应用终末期肝病模型评分(而非终末期肝病模型钠评分)。
Eur J Gastroenterol Hepatol. 2021 Apr 1;33(4):541-546. doi: 10.1097/MEG.0000000000001760.
8
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes.经颈静脉肝内门体分流术(TIPS):当前适应证及改善治疗效果的策略
Intern Emerg Med. 2020 Jan;15(1):37-48. doi: 10.1007/s11739-019-02252-8. Epub 2020 Jan 9.
9
Risk prediction scores for acute on chronic liver failure development and mortality.慢性肝衰竭急性发作发展和死亡率的风险预测评分。
Liver Int. 2020 May;40(5):1159-1167. doi: 10.1111/liv.14328. Epub 2019 Dec 26.
10
Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.两种定义下代偿性肝硬化患者慢加急性肝衰竭的发生率和死亡率。
Hepatology. 2019 May;69(5):2150-2163. doi: 10.1002/hep.30494. Epub 2019 Mar 20.